Dendreon (DNDN) Discloses Restructuring Efforts: Cutting 500 Jobs, COO Leaving; Sees PROVENGE Sales of $22M in Aug.
Tweet Send to a Friend
Dendreon Corporation (Nasdaq: DNDN) today announced restructuring plans, overall cost reductions, and an update on PROVENGE (sipuleucel-T) sales.
This article: 139 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 139 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
